Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — A blood cancer treatment from GSK helped patients live longer in ...
Antivirals have historically made up the bulk of licenses that allow generic companies to copy innovative drugs for poorer countries. Now, GSK’s ViiV Healthcare is adding the world’s first long-acting ...
Pharma giant GlaxoSmithKline on Tuesday announced a deal to buy Canadian biotech Bellus Health for $2 billion, betting big on the firm’s cough medicine as it moves to shore up its slender drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback